Nasolabial Folds Clinical Trial
Official title:
A Single Center, Prospective, Comparative, Randomized, Double-blinded(Subject, Evaluator), Non-inferiority, Pivotal Clinical Study to Evaluate the Efficacy and Safety of the Polydioxanone Suture 'BRFS-18G-S100WH' Compared to 'MINT Lift FINE+' for Correction of the Nasolabial Folds
Verified date | January 2024 |
Source | Hugel |
Contact | Cho Long Park |
Phone | +82-2-6966-1654 |
clpark[@]hugel.co.kr | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Evaluate the Safety and Efficacy of 'BRFS-18G-S100WH' as Compared to 'MINT Lift FINE+' in Subject With Nasolabial Folds.
Status | Recruiting |
Enrollment | 106 |
Est. completion date | October 30, 2025 |
Est. primary completion date | July 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: 1. Adults over 19 years of age 2. Those who wish to temporarily improve nasolabial folds on both sides of the face and have a score of 3 (Moderate) or 4 (Severe) on the WSRS (Wrinkle Severity Rating Scale) 3. Those who voluntarily decided to participate in this clinical trial and agreed to the subject description and consent form in writing Exclusion Criteria: 1. A person who has undergone a procedure using filler or facial tissue fixation thread on the facial area. 2. Those who are pregnant or lactating |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Hugel Inc. | Seoul |
Lead Sponsor | Collaborator |
---|---|
Hugel | Jworld |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement rate (%) at 12 weeks after the procedure compared to baseline. | Improvement rate (%) at 12 weeks after the procedure compared to baseline by an independent evaluator. | Baseline to week 12 | |
Secondary | WSRS evaluation by an independent evaluator | Improvement rate (%): 4, 8, and 24 weeks after treatment. Baseline score change (points): 4, 8, 12, and 24 weeks after the procedure. | Baseline to week 4, 8, 24 | |
Secondary | WSRS evaluation by tester | Improvement rate (%): 4, 8, and 24 weeks after treatment. Baseline score change (points): 4, 8, 12, and 24 weeks after the procedure. | Baseline to week 4, 8, 24 | |
Secondary | Satisfaction level (%) at 4, 8, 12, and 24 weeks after the procedure compared to the baseline. | Satisfaction level (%) at 4, 8, 12, and 24 weeks after the procedure compared to the baseline by the subject | Baseline to week 4, 8, 12, 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06018987 -
A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds
|
Phase 2/Phase 3 | |
Completed |
NCT01012661 -
Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler
|
Phase 4 | |
Completed |
NCT01115634 -
Autologous Fibroblast Transplantation in Facial Deformities
|
Phase 2 | |
Completed |
NCT00778531 -
Protocol for the Post-approval Study of ArteFill® for Correction of Nasolabial Folds
|
Phase 4 | |
Completed |
NCT03932045 -
A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds
|
N/A | |
Completed |
NCT02647853 -
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01069354 -
Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds
|
N/A | |
Completed |
NCT00850889 -
Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds
|
Phase 4 | |
Completed |
NCT00797459 -
Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds
|
N/A | |
Recruiting |
NCT06093321 -
A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement
|
N/A | |
Not yet recruiting |
NCT06295172 -
A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement
|
N/A | |
Completed |
NCT01060943 -
An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds
|
Phase 3 | |
Completed |
NCT05612958 -
Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds
|
N/A | |
Completed |
NCT02672644 -
Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep
|
Phase 4 | |
Completed |
NCT01012388 -
Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
|
Phase 4 | |
Completed |
NCT01635855 -
Belotero Post Approval Study
|
Phase 4 | |
Completed |
NCT02179736 -
A Post Market Evaluation After Treatment of Nasolabial Folds
|
N/A | |
Terminated |
NCT00716443 -
Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections
|
Phase 4 | |
Recruiting |
NCT02607670 -
Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds
|
Phase 2 | |
Completed |
NCT00823069 -
Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
|
N/A |